Yahoo · Aug 7, 2026
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Hamilton Lane (HLNE) have what it takes? Let's find out.
HL
NASDAQ · HLNE
Hamilton Lane Incorporated
Financial Services · Asset Management
$107.19
Up+$3.90 (+3.78%)
Updated Aug 14, 2026, 2:10 AM
SID Score
5.1/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 7.49B
- P/E ratio
- 24.26
- Dividend yield
- 2.43%
- 52-week range
- $71.88 – $161.13
- Volume
- 559.48K
- Avg. volume
- 521.74K
Price performance
HLNE price history
1M range · 0 trading sessions · Daily adjusted prices
HLNE does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest HLNE news
The latest Smart Investors Daily articles mentioning HLNE.
Stock researchCompany · Overview
HLNE research
Overview
Company profile and research snapshot.
Company profile
Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $166.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | Keefe, Bruyette & Woods | Outperform | — |
| Aug 5, 2026 | Oppenheimer | Outperform | — |
| Aug 5, 2026 | UBS | Buy | — |
| Jul 21, 2026 | Morgan Stanley | Equal-Weight | — |
| Jul 17, 2026 | Oppenheimer | Outperform | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 5, 2026
UBS Maintains Buy on Hamilton Lane, Raises Price Target to $131
UBS analyst Michael Brown maintains Hamilton Lane (NASDAQ:HLNE) with a Buy and raises the price target from $114 to $131.
Benzinga · Aug 5, 2026
Oppenheimer Maintains Outperform on Hamilton Lane, Raises Price Target to $182
Oppenheimer analyst Chris Kotowski maintains Hamilton Lane (NASDAQ:HLNE) with a Outperform and raises the price target from $174 to $182.
Benzinga · Aug 5, 2026
Keefe, Bruyette & Woods Maintains Outperform on Hamilton Lane, Raises Price Target to $116
Keefe, Bruyette & Woods analyst Kyle Voigt maintains Hamilton Lane (NASDAQ:HLNE) with a Outperform and raises the price target from $105 to $116.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
